Specificity of skin test with varicella-zoster virus antigen in varicella-zoster and herpes simplex virus infections. 1987

K Baba, and K Shiraki, and T Kanesaki, and K Yamanishi, and P L Ogra, and H Yabuuchi, and M Takahashi
Department of Pediatrics, School of Medicine, Osaka University, Japan.

Specificity of the skin test with varicella-zoster virus (VZV) antigen was examined in guinea pigs infected with herpes simplex virus (HSV) type 1 or VZV and in children with a history of HSV infection who developed varicella. Infected guinea pigs responded positively only to homologous virus. No cross-reaction between HSV and VZV was detected in the skin test, as well as in the neutralization test in infected guinea pigs, suggesting that the VZV skin test is specific for immunity to VZV infection. Twelve children were infected with HSV during an HSV epidemic and subsequently developed varicella in institutional settings. During the 2.5-month period between the HSV and VZV infections, the immune status of the children to VZV was negative both in the skin test and in the antibody test, although antibody to HSV was detected by an immune adherence hemagglutination test. After VZV infection, all responded positively both in the skin test and in the antibody test (immune adherence hemagglutination test) to VZV. These results suggest that the VZV skin test is specific for immunity to VZV infection, not cross-reactive to HSV infection in humans. This specificity will be of value in screening susceptibility or immunity to VZV, irrespective of prior HSV infection.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D002644 Chickenpox A highly contagious infectious disease caused by the varicella-zoster virus (HERPESVIRUS 3, HUMAN). It usually affects children, is spread by direct contact or respiratory route via droplet nuclei, and is characterized by the appearance on the skin and mucous membranes of successive crops of typical pruritic vesicular lesions that are easily broken and become scabbed. Chickenpox is relatively benign in children, but may be complicated by pneumonia and encephalitis in adults. (From Dorland, 27th ed) Varicella,Chicken Pox
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006561 Herpes Simplex A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.) Herpes Simplex Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D012882 Skin Tests Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity. Skin Test,Test, Skin,Tests, Skin

Related Publications

K Baba, and K Shiraki, and T Kanesaki, and K Yamanishi, and P L Ogra, and H Yabuuchi, and M Takahashi
July 1984, American journal of ophthalmology,
K Baba, and K Shiraki, and T Kanesaki, and K Yamanishi, and P L Ogra, and H Yabuuchi, and M Takahashi
January 1980, Archives of dermatological research,
K Baba, and K Shiraki, and T Kanesaki, and K Yamanishi, and P L Ogra, and H Yabuuchi, and M Takahashi
December 1984, American journal of ophthalmology,
K Baba, and K Shiraki, and T Kanesaki, and K Yamanishi, and P L Ogra, and H Yabuuchi, and M Takahashi
October 2022, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG,
K Baba, and K Shiraki, and T Kanesaki, and K Yamanishi, and P L Ogra, and H Yabuuchi, and M Takahashi
October 2003, Therapeutische Umschau. Revue therapeutique,
K Baba, and K Shiraki, and T Kanesaki, and K Yamanishi, and P L Ogra, and H Yabuuchi, and M Takahashi
January 1992, Heart & lung : the journal of critical care,
K Baba, and K Shiraki, and T Kanesaki, and K Yamanishi, and P L Ogra, and H Yabuuchi, and M Takahashi
September 2002, The Medical journal of Australia,
K Baba, and K Shiraki, and T Kanesaki, and K Yamanishi, and P L Ogra, and H Yabuuchi, and M Takahashi
March 1997, The Western journal of medicine,
K Baba, and K Shiraki, and T Kanesaki, and K Yamanishi, and P L Ogra, and H Yabuuchi, and M Takahashi
June 2012, Journal of the American Academy of Dermatology,
K Baba, and K Shiraki, and T Kanesaki, and K Yamanishi, and P L Ogra, and H Yabuuchi, and M Takahashi
February 2023, Viruses,
Copied contents to your clipboard!